8279.TWO · SYNGEN
Taiwan · RS rating 18 · As of 2026-10-08
| Price | 80.90 TWD |
|---|---|
| 1-day change | +0.1% |
| RS rating (overall / 1M / 3M / 12M) | 18 / 67 / 33 / 12 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 37 / 13 / 38 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +108.9% |
| Sales growth Q/Q | +42.4% |
| Distance from 52-week high | +41.0% |
| Market cap (USD) | $67.5M |